• +353-1-415-1241(GMT OFFICE HOURS)
  • 1-800-526-8630(US/CAN TOLL FREE)
  • 1-917-300-0470(EST OFFICE HOURS)

PRODUCT FILTERS

REGION

14
10
9
8
8

COUNTRY

2
1
1
1
1

CATEGORIES

  • 39
  • 5
  • 4

PRICE

3
42
43
46

PUBLISHED

0
0
1
46

PRODUCT TYPE

43
3

Search "Health Care Reform Now!. A Prescription for Change - DUPLICATE" returned 46 results.

PRODUCT TITLE

Health Care Reform Now!. A Prescription for Change

The United States spends more money on health care by far than any other country and yet nearly 50,000,000 Americans are uninsured at least part of the time each year. Health Care Reform Now! is...

August 2007

Rx-to-OTC Switching Strategies - New Switching Opportunities in Weight Management and Smoking Cessation, but Encouraging the Uptake of Self-Medication Remains a Challenge

Rx-to-OTC Switching Strategies - New Switching Opportunities in Weight Management and Smoking Cessation, but Encouraging the Uptake of Self-Medication Remains a Challenge Summary GBI Research, a leading...

April 2012
FROM

Plunkett's Health Care Industry Almanac 2014: Health Care Industry Market Research, Statistics, Trends & Leading Companies

Plunkett's Health Care Industry Almanac 2014 is a complete market research report, including forecasts and market estimates, technologies analysis and developments at innovative firms You will gain...

November 2013
FROM

Moldova Pharmaceuticals and Healthcare Report Q1 2012

Business Monitor International's Moldova Pharmaceuticals and Healthcare Report provides industry professionals and strategists, corporate analysts, pharmaceutical associations, government departments...

January 2012
UK Pharmaceutical Market Overview - Pricing and reimbursement challenges dampen future growth UK Pharmaceutical Market Overview - Pricing and reimbursement challenges dampen future growth - Product Thumbnail Image

UK Pharmaceutical Market Overview - Pricing and reimbursement challenges dampen future growth

Introduction The UK prescription pharmaceutical market was valued at $28.4 billion in 2009. Key growth drivers include growing use of chronic high-value innovative treatments driven by a rising elderly...

June 2010
FROM

Plastic Surgery Markets

Modern advances in plastic surgery have allowed patients with severe physical deformities to live normal lives Where at one time an individual suffering from an extreme physical abnormality simply had...

October 2010
FROM

Clinical Trials in Psychopharmacology. A Better Brain. 2nd Edition

Although clinical trials were virtually unheard of in psychiatry for many years, they are now the gold standard for judging whether drugs are safe and useful. But should they be? What is the true status...

January 2010

Executive Report on Strategies in Angola

How to Strategically Evaluate Angola Perhaps the most efficient way of evaluating Angola is to consider key dimensions which themselves are composites of multiple factors. Composite portfolio approaches...

June 2007

Executive Report on Strategies in Vietnam

How to Strategically Evaluate Vietnam Perhaps the most efficient way of evaluating Vietnam is to consider key dimensions which themselves are composites of multiple factors. Composite portfolio approaches...

June 2007

Executive Report on Strategies in Algeria

How to Strategically Evaluate Algeria Perhaps the most efficient way of evaluating Algeria is to consider key dimensions which themselves are composites of multiple factors. Composite portfolio approaches...

June 2007

Executive Report on Strategies in Bosnia and Herzegovina

How to Strategically Evaluate Bosnia and Herzegovina Perhaps the most efficient way of evaluating Bosnia and Herzegovina is to consider key dimensions which themselves are composites of multiple factors....

June 2007

Executive Report on Strategies in Uzbekistan

How to Strategically Evaluate Uzbekistan Perhaps the most efficient way of evaluating Uzbekistan is to consider key dimensions which themselves are composites of multiple factors. Composite portfolio...

June 2007

Executive Report on Strategies in Ukraine

How to Strategically Evaluate Ukraine Perhaps the most efficient way of evaluating Ukraine is to consider key dimensions which themselves are composites of multiple factors. Composite portfolio approaches...

June 2007

Executive Report on Strategies in Bulgaria

How to Strategically Evaluate Bulgaria Perhaps the most efficient way of evaluating Bulgaria is to consider key dimensions which themselves are composites of multiple factors. Composite portfolio...

June 2007

Executive Report on Strategies in Bangladesh

How to Strategically Evaluate Bangladesh Perhaps the most efficient way of evaluating Bangladesh is to consider key dimensions which themselves are composites of multiple factors. Composite portfolio...

June 2007

Executive Report on Strategies in Nigeria

How to Strategically Evaluate Nigeria Perhaps the most efficient way of evaluating Nigeria is to consider key dimensions which themselves are composites of multiple factors. Composite portfolio approaches...

June 2007

Executive Report on Strategies in Egypt

How to Strategically Evaluate Egypt Perhaps the most efficient way of evaluating Egypt is to consider key dimensions which themselves are composites of multiple factors. Composite portfolio approaches...

June 2007

Executive Report on Strategies in Cyprus

How to Strategically Evaluate Cyprus Perhaps the most efficient way of evaluating Cyprus is to consider key dimensions which themselves are composites of multiple factors. Composite portfolio approaches...

June 2007

Executive Report on Strategies in Ecuador

How to Strategically Evaluate Ecuador Perhaps the most efficient way of evaluating Ecuador is to consider key dimensions which themselves are composites of multiple factors. Composite portfolio approaches...

June 2007

Executive Report on Strategies in Kazakhstan

How to Strategically Evaluate Kazakhstan Perhaps the most efficient way of evaluating Kazakhstan is to consider key dimensions which themselves are composites of multiple factors. Composite portfolio...

June 2007
Loading Indicator